Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in APLS / Apellis Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 14,925 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 233,900 of underlying shares valued at $5,875,568 USD and put options representing 93,900 of underlying shares valued at $2,358,768 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -14,925 -100.00 0 -100.00
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 14,925 -1,853 -11.04 338 16.21 0.0006
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 16,778 -13,263 -44.15 290 -55.79 0.0006
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 30,041 30,041 657 0.0019
2025-05-14 2024-12-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 0 -42,153 -100.00 0 -100.00
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -42,153 0
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 42,153 7,454 21.48 1,216 -8.72 0.0035
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 34,699 34,699 1,331 0.0052
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -253,905 -100.00 0 -100.00
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 253,905 27,221 12.01 15,199 76.25 0.0400
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 226,684 207,866 1,104.61 8,623 403.09 0.0290
2023-08-09 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 18,818 13,908 283.26 1,714 430.65 0.0055
2023-05-12 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 4,910 -45,913 -90.34 324 -87.71 0.0012
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 50,823 50,823 2,628 0.0061
2022-11-09 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -25,823 -100.00 0 -100.00
2022-08-11 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 25,823 -29,723 -53.51 1,168 -58.61 0.0018
2022-05-12 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 55,546 19,525 54.20 2,822 65.71 0.0028
2022-02-11 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 36,021 -69,731 -65.94 1,703 -51.15 0.0014
2021-11-12 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 105,752 105,752 3,486 0.0038
2021-02-10 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -1,629 -100.00 0 -100.00
2020-11-12 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 1,629 1,629 49 0.0002
2020-02-10 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -100 -100.00 0 -100.00
2019-11-12 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 100 100 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS COM Call 233,900 30.60 5,876 44.95 n/a n/a n/a
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS COM Call 179,100 23.01 4,053 60.83 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Call 145,600 -30.07 2,520 -44.65 n/a n/a n/a
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM Call 208,200 -24.92 4,553 -48.54 n/a n/a n/a
2025-05-14 2024-12-31 13F/A APELLIS PHARMACEUTICALS COM Call 277,300 -18.94 8,849 -10.32 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Call 277,300 8,849 n/a n/a n/a
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM Call 342,100 22.35 9,866 -8.01 n/a n/a n/a
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM Call 279,600 23.66 10,725 -19.30 n/a n/a n/a
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM Call 226,100 -38.17 13,290 -39.29 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Call 365,700 -61.28 21,891 -39.07 n/a n/a n/a
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM Call 944,400 1,511.60 35,925 572.99 n/a n/a n/a
2023-08-09 2023-06-30 13F APELLIS PHARMACEUTICALS COM Call 58,600 -46.68 5,338 -26.36 n/a n/a n/a
2023-05-12 2023-03-31 13F APELLIS PHARMACEUTICALS COM Call 109,900 8.28 7,249 38.13 n/a n/a n/a
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM Call 101,500 62.92 5,249 23.34 n/a n/a n/a
2022-11-09 2022-09-30 13F APELLIS PHARMACEUTICALS COM Call 62,300 25.86 4,255 90.13 n/a n/a n/a
2022-08-11 2022-06-30 13F APELLIS PHARMACEUTICALS COM Call 49,500 17.02 2,238 4.14 n/a n/a n/a
2022-05-12 2022-03-31 13F APELLIS PHARMACEUTICALS COM Call 42,300 110.45 2,149 126.21 n/a n/a n/a
2022-02-11 2021-12-31 13F APELLIS PHARMACEUTICALS COM Call 20,100 -78.15 950 -68.67 n/a n/a n/a
2021-11-12 2021-09-30 13F APELLIS PHARMACEUTICALS COM Call 92,000 3.25 3,032 -46.16 n/a n/a n/a
2021-08-10 2021-06-30 13F APELLIS PHARMACEUTICALS COM Call 89,100 -28.38 5,631 5.49 n/a n/a n/a
2021-05-12 2021-03-31 13F APELLIS PHARMACEUTICALS COM Call 124,400 48.98 5,338 11.77 n/a n/a n/a
2021-02-10 2020-12-31 13F APELLIS PHARMACEUTICALS COM Call 83,500 2,882.14 4,776 5,585.71 n/a n/a n/a
2020-11-12 2020-09-30 13F APELLIS PHARMACEUTICALS COM Call 2,800 -96.30 84 -96.60 n/a n/a n/a
2020-08-13 2020-06-30 13F APELLIS PHARMACEUTICALS COM Call 75,700 2.16 2,472 24.53 n/a n/a n/a
2020-05-13 2020-03-31 13F APELLIS PHARMACEUTICALS COM Call 74,100 474.42 1,985 402.53 n/a n/a n/a
2020-02-10 2019-12-31 13F APELLIS PHARMACEUTICALS COM Call 12,900 395 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS COM Put 93,900 -11.91 2,359 -2.24 n/a n/a n/a
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS COM Put 106,600 95.60 2,412 155.78 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Put 54,500 -38.21 943 -51.09 n/a n/a n/a
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM Put 88,200 -44.25 1,929 -61.81 n/a n/a n/a
2025-05-14 2024-12-31 13F/A APELLIS PHARMACEUTICALS COM Put 158,200 -32.99 5,048 -25.86 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Put 158,200 5,048 n/a n/a n/a
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM Put 236,100 44.76 6,809 8.84 n/a n/a n/a
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM Put 163,100 -38.61 6,257 -59.94 n/a n/a n/a
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM Put 265,700 -2.06 15,618 -3.84 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Put 271,300 -36.88 16,240 -0.67 n/a n/a n/a
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM Put 429,800 248.58 16,350 45.56 n/a n/a n/a
2023-08-09 2023-06-30 13F APELLIS PHARMACEUTICALS COM Put 123,300 125.41 11,233 211.31 n/a n/a n/a
2023-05-12 2023-03-31 13F APELLIS PHARMACEUTICALS COM Put 54,700 -68.92 3,608 -60.35 n/a n/a n/a
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM Put 176,000 174.14 9,101 107.53 n/a n/a n/a
2022-11-09 2022-09-30 13F APELLIS PHARMACEUTICALS COM Put 64,200 -33.68 4,385 0.18 n/a n/a n/a
2022-08-11 2022-06-30 13F APELLIS PHARMACEUTICALS COM Put 96,800 -34.46 4,377 -41.68 n/a n/a n/a
2022-05-12 2022-03-31 13F APELLIS PHARMACEUTICALS COM Put 147,700 53.06 7,505 64.48 n/a n/a n/a
2022-02-11 2021-12-31 13F APELLIS PHARMACEUTICALS COM Put 96,500 -57.43 4,563 -38.93 n/a n/a n/a
2021-11-12 2021-09-30 13F APELLIS PHARMACEUTICALS COM Put 226,700 547.71 7,472 237.79 n/a n/a n/a
2021-08-10 2021-06-30 13F APELLIS PHARMACEUTICALS COM Put 35,000 644.68 2,212 995.05 n/a n/a n/a
2021-05-12 2021-03-31 13F APELLIS PHARMACEUTICALS COM Put 4,700 -21.67 202 -41.11 n/a n/a n/a
2021-02-10 2020-12-31 13F APELLIS PHARMACEUTICALS COM Put 6,000 343 n/a n/a n/a
2020-11-12 2020-09-30 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F APELLIS PHARMACEUTICALS COM Put 6,800 0.00 222 21.98 n/a n/a n/a
2020-05-13 2020-03-31 13F APELLIS PHARMACEUTICALS COM Put 6,800 -67.31 182 -71.43 n/a n/a n/a
2020-02-10 2019-12-31 13F APELLIS PHARMACEUTICALS COM Put 20,800 637 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.